跳至主要内容
临床试验/NCT01217320
NCT01217320Unknown不适用

Efficacy and Safety of Creatine Supplementation in Patients With Juvenile Systemic Lupus Erythematosus and Juvenile Dermatomyositis

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
muscle strength

研究概览

简要总结

Creatine supplementation may improve strength, muscle mass, bone mass and muscle function in healthy and elderly people. The investigators speculate that creatine supplementation could have therapeutic effects in pediatric rheumatic (i.e., juvenile systemic lupus erythematosus and juvenile dermatomyositis) patients who usually present muscle weakness, muscle wasting and bone mass loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed with lupus systemic erythematosus and juvenile dermatomyositis
  • physically inactive
  • stable pharmacological treatment

排除标准

  • macroalbuminuria
  • GFR < 30 mL/min/1.73m2
  • use of oral anticontraceptive agents
  • pregnancy
  • diabetes mellitus
  • hypothyroidism

研究组 & 干预措施

creatine supplementation

Experimental

will receive 5g/d of creatine monohydrate throughout the trial

干预措施: creatine (Dietary Supplement)

placebo

Placebo Comparator

will receive 5g/d of placebo (dextrose) throughout the trial

干预措施: placebo (dextrose) (Dietary Supplement)

结局指标

主要结局

muscle strength

时间窗: after six months

次要结局

  • muscle function(after six months)
  • kidney function parameters(after six months)
  • quality of life(after six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bruno Gualano

Principal Investigator

University of Sao Paulo

研究点 (2)

Loading locations...

相似试验